Childhood ovarian cancers. New advances in treatment

M. S. Piver, J. Lurain

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

From 1968 to 1978, 30 patients, age 4 to 20, with ovarian malignant growths were admitted to Roswell Park Memorial Institute. Recent advances in the treatment of childhood ovarian cancers have led to a significant improvement in survival rates. These therapeutic modalities include whole abdominal irradiation with or without mediastinal and left supraclavicular irradiation in children with ovarian dysgerminoma, the use of vincristine sulfate, actinomycin-D, and cyclophosphamide as adjunctive therapy in children with stage IA immature teratoma or endodermal sinus tumor, and high-dose methotrexate plus cyclophosphamide in metastatic epithelial ovarian cancer. In children with a unilateral ovarian stromal tumor, conservative surgery with preservation of future child-bearing potential should be carried out.

Original languageEnglish (US)
Pages (from-to)1196-1199
Number of pages4
JournalNew York State Journal of Medicine
Volume79
Issue number8
StatePublished - Dec 1 1979

Fingerprint

Ovarian Neoplasms
Cyclophosphamide
Dysgerminoma
Endodermal Sinus Tumor
Teratoma
Dactinomycin
Vincristine
Therapeutics
Methotrexate
Survival Rate
Growth
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{094f11960ecf4e7485b98c6274d42980,
title = "Childhood ovarian cancers. New advances in treatment",
abstract = "From 1968 to 1978, 30 patients, age 4 to 20, with ovarian malignant growths were admitted to Roswell Park Memorial Institute. Recent advances in the treatment of childhood ovarian cancers have led to a significant improvement in survival rates. These therapeutic modalities include whole abdominal irradiation with or without mediastinal and left supraclavicular irradiation in children with ovarian dysgerminoma, the use of vincristine sulfate, actinomycin-D, and cyclophosphamide as adjunctive therapy in children with stage IA immature teratoma or endodermal sinus tumor, and high-dose methotrexate plus cyclophosphamide in metastatic epithelial ovarian cancer. In children with a unilateral ovarian stromal tumor, conservative surgery with preservation of future child-bearing potential should be carried out.",
author = "Piver, {M. S.} and J. Lurain",
year = "1979",
month = "12",
day = "1",
language = "English (US)",
volume = "79",
pages = "1196--1199",
journal = "New York State Journal of Medicine",
issn = "0028-7628",
number = "8",

}

Childhood ovarian cancers. New advances in treatment. / Piver, M. S.; Lurain, J.

In: New York State Journal of Medicine, Vol. 79, No. 8, 01.12.1979, p. 1196-1199.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Childhood ovarian cancers. New advances in treatment

AU - Piver, M. S.

AU - Lurain, J.

PY - 1979/12/1

Y1 - 1979/12/1

N2 - From 1968 to 1978, 30 patients, age 4 to 20, with ovarian malignant growths were admitted to Roswell Park Memorial Institute. Recent advances in the treatment of childhood ovarian cancers have led to a significant improvement in survival rates. These therapeutic modalities include whole abdominal irradiation with or without mediastinal and left supraclavicular irradiation in children with ovarian dysgerminoma, the use of vincristine sulfate, actinomycin-D, and cyclophosphamide as adjunctive therapy in children with stage IA immature teratoma or endodermal sinus tumor, and high-dose methotrexate plus cyclophosphamide in metastatic epithelial ovarian cancer. In children with a unilateral ovarian stromal tumor, conservative surgery with preservation of future child-bearing potential should be carried out.

AB - From 1968 to 1978, 30 patients, age 4 to 20, with ovarian malignant growths were admitted to Roswell Park Memorial Institute. Recent advances in the treatment of childhood ovarian cancers have led to a significant improvement in survival rates. These therapeutic modalities include whole abdominal irradiation with or without mediastinal and left supraclavicular irradiation in children with ovarian dysgerminoma, the use of vincristine sulfate, actinomycin-D, and cyclophosphamide as adjunctive therapy in children with stage IA immature teratoma or endodermal sinus tumor, and high-dose methotrexate plus cyclophosphamide in metastatic epithelial ovarian cancer. In children with a unilateral ovarian stromal tumor, conservative surgery with preservation of future child-bearing potential should be carried out.

UR - http://www.scopus.com/inward/record.url?scp=0018760560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018760560&partnerID=8YFLogxK

M3 - Article

VL - 79

SP - 1196

EP - 1199

JO - New York State Journal of Medicine

JF - New York State Journal of Medicine

SN - 0028-7628

IS - 8

ER -